Ozan KOCAK, Kürşat Bora CARMAN, Çoşkun YARAR, Sevgi YİMENCİOĞLU

Tü beroskleroz Kompleksi Hastalarının Klinik ve Demografik Ö zellikleri

Tüberoskleroz kompleksi, sık görülen, birçok organ ve sistemi etkileyen nörokutanöz hastalıklardan biridir. Neden olduğu epilepsi ve nöropsikiyatrik bozukluklar sonucunda hasta ve ailesi için ciddi sağlık ve sosyal problemler oluşmasına yol açar. Biz bu çalışmada kliniğimizde takip ettiğimiz 27 tüberoskleroz kompleks hastasını sunmayı amaçladık. Retrospektif olarak planlanan bu çalışmada, Çocuk Nörolojisi Kliniği’nde 2000-2005 yılları arasında tüberoskleroz kompleks tanısı ile takip edilen 27 hasta çalışmaya alındı. Hastaların, klinik, laboratuvar ve demografik verileri geriye dönük olarak derlendi. Çalışmaya alınan hastaların 15’i (%55,6) erkek ve 12’si (%44,4)kadın idi. Hastaların tanı almadan önce hastaneye başvuru şikayetlerine bakıldığında, 22 (%81,5) hastanın nöbet geçirme nedeni ile, 4 hastanın (%14,8) hipopigmente döküntü nedeni ile ve bir hastanın (%3,7) karın ağrısı nedeni ile hastaneye başvurduğu görüldü. Nöbet geçiren 13 (%48,1) hastada jeneralize nöbet, 6 hastada infantil spasm(%22,2), 3 hastada(%11,1) fokal nöbet saptandı. Ortalama nöbet geçirme yaşı 28 ±7,2 aydı. Hastalığın diğer bulguları arasında, ciltte hipomelanotik maküller hastaların hepsinde vardı. Dokuz hastada (%33,3) yüzde anjiofibrom vardı. Çalışmamızda hastaların, literatürle uyumlu olarak, en sık nöbet geçirme nedeni ile hastaneye başvurduktan sonra tanı aldıkları görüldü. Ancak karın ağrısı gibi tipik olmayan bir yakınma ile başvuran hastamızda mevcuttu. Görüntüleme yöntemlerinin daha ulaşılabilir olmasına rağmen, tanı yaşının 13 yıla kadar uzadığı tespit edildi. Özellikle nöbet geçiren hastalarda yapılacak cilt muayenesinin, halen tüberoskleroz hastalığının tanısı için en önemli yöntem olduğunu hatırlatmak istiyoruz.

Clinical and Demographic Featüres of Tüberoüs Sclerosis Complex Patients

The tuberous sclerosis complex is one of the most common neurocutaneous diseases affecting many organs and systems. It causes serious health and social problems for the patient and his family as a result of epilepsy and neuropsychiatric disorders. In this study, we aimed to present 27 patients with tuberous sclerosis complex who were followed in our clinic. This retrospective study, include 27 patients with the diagnosis of tuberous sclerosis complex who were followed up in the Pediatric Neurology Clinic between 2000 and 2005 years. Clinical, laboratory and demographic data of the patients were reviewed retrospectively. Fifteen patients (55.6%) were male and 12 patients (44.4%) were female. When the patients were admitted to hospital before diagnosis, 22 (81.5%) patients had seizures, 4 (14.8%) had hypopigmented rash and one (3.7%) had abdominal pain. . Generalized seizures were seen in 13 patients (48.1%), infantile spasm in 6 patients (22.2%) and focal seizures in 3 patients (11.1%). The mean age at seizure was 28 ± 7.2 months. Among the other findings of the disease, hypomelanotic macules on the skin were present in all patients. Nine patients (33.3%) had angiofibroma. In our study, It was observed that the complaint at presentation was seizure. However, as in a patient in our study, it was observed that TSC patients may present to the hospital with abdominal pain. Although imaging methods were more accessible, the age at diagnosis may extended to 13 years. We would like to remind that skin examination, especially in patients with seizures, is still the most important method for the diagnosis of TSC

PDF

___

1. Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;23;372(9639):657-68.
2. Bourneville DM. Sclerose tubereuse der circonvolutions cerebrales: idiotie et epilepsie hemiplegique. Arch Neurol 1880; 81-91.
3. Jülich K, Sahin M. Mechanism-based treatment in tuberous sclerosis complex. Pediatr Neurol. 2014;50:290-6.
4. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell.1993; 31;75:1305-15.
5. Schwartz RA, Fernández G, Kotulska K, Jo´zwiak S. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol. 2007; 57: 189-202
6. Northrup H, Krueger DA. International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013; 49: 243-54.
7. KrishnanA, Kaza RK, Vummidi DR. Crosssectional imaging review of tuberous sclerosis. Radiol Clin North. Am. 2016;54:423-40.
8. Grajkowska W, Kotulska K, Jurkiewicz E, Matyja E. Brain lesions in tuberous sclerosis complex. Folia Neuropathol. 2010;48:139–49
9. Beaumont TL, Limbrick DD, Smyth MD. Advances in the management of subependymal giant cell astrocytoma. Childs Nerv Syst. 2012;28:963-8
10. Henske EP, Józwiak S, Kingswood JC, Sampson JR, Thiele EA. Tuberous sclerosis complex. Nat Rev Dis Primers. 2016;26;2:16035
11. Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia. 2008;49:8-21.
12. Thiele EA, Granata T, Matricardi S, Chugani HT. Transition into adulthood: Tuberous sclerosis complex, Sturge-Weber syndrome, and Rasmussen encephalitis. Epilepsia. 2014;55 Suppl 3:29-33.
13. Both P, Ten Holt L, Mous S, Patist J, Rietman A, Dieleman G, Ten Hoopen L, Vergeer M, de Wit MC, Bindels-de Heus K, Moll H, van Eeghen A et al. Tuberous sclerosis complex: Concerns and needs of patients and parents from the transitional period to adulthood. Epilepsy Behav. 2018;83:13-21
14. Peron A, Vignoli A, LaBriola F, Morenghi E, Tansini L, Alfano RM et al. TSC Study Group of the San Paolo Hospital of Milan. Deep phenotyping of patients with tuberous sclerosis complex and no mutation identified in TSC1 and TSC2. Eur J Med Genet. 2018;61:403-10.
15. Wilde L, Eden K, de Vries P, Moss J, Welham A, Oliver C et al. Self-injury and aggression in adults with tuberous sclerosis complex: Frequency, associated person characteristics, and implications for assessment. Res Dev Disabil. 2017;64:119-30
16. Vignoli A, La Briola F, Peron A, Turner K, Vannicola C, Saccani M, Magnaghi E, Scornavacca GF, Canevini MP et al. Autism spectrum disorder in tuberous sclerosis complex: Searching for risk markers. Orphanet J Rare Dis. 2015;2;10:154.
17. Pirson Y. Tuberous sclerosis complexassociated kidney angiomyolipoma: from contemplation to action. Nephrol Dial Transplant. 2013;28:1680-5
18. Stillwell TJ, Gomez MR, Kelalis PP. Renal lesions in tuberous sclerosis. J Urol. 1987;138:477-81
19. Tsai JD, Wei CC, Chen SM, Lue KH, Sheu JN et al. Association between the growth rate of renal cysts/angiomyolipomas and age in the patients with tuberous sclerosis complex. Int Urol Nephrol. 2014;46:1685-90
20. Shepherd C, Gomez M, Lie J, Crowson C et al. Causes of death in patients with tuberous sclerosis. Mayo Clinic Proceedings. 1991;66, 792-6
21. Hamer HM, Pfäfflin M, Baier H, Bösebeck F, Franz M, Holtkamp M, et al. Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers. Epilepsy Behav. 2018;82:64-7
22. Webb DW, Thomas RD, Osborne JP. Cardiac rhabdomyomas and their association with tuberous sclerosis. Arch Dis Child. 1993; 68: 367-70.
23. Cudzilo CJ, Szczesniak RD, Brody AS, Rattan MS, Krueger DA, Bissler JJ, Franz DN, McCormack FX, Young LR. Lymphangioleiomyomatosis screening in women with tuberous sclerosis. Chest. 2013;144:578-85.
24. Rowley SA, O’Callaghan FJ, Osborne JP. Ophthalmic manifestations of tuberous sclerosis: a population based study. Br J Ophthalmol. 2001; 85: 420-3
25. Avila NA, Dwyer AJ, Rabel A, Darling T, Hong CH, Moss J. CT of sclerotic bone lesions: Imaging features differentiating tuberous sclerosis complex with lymphangioleiomyomatosis from sporadic lymphangioleiomymatosis. Radiology. 2010 ;254:851-7.